Novo Nordisk Flags. Courtesy of Novo Nordisk.

Oral semaglutide did not slow Alzheimer’s progression in the EVOKE trials, despite favorable biomarker shifts.

jcst2d.com/index.php/ne...

#Semaglutide #EVOKETrials #Alzheimers #ClinicalTrialResults #MetabolicHealth